- Open Access
Erratum to: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
Cancer Cell International volume 11, Article number: 10 (2011)
Bikeye Ngwabyt Sandra-Nadia, Colin Carole, Marie Yannick, Vampouille Raphaël, Ravassard Philippe, Rousseau Audrey, Boisselier Blandine, Idbaih Ahmed, Calvo Félix Charles, Leuraud Pascal, Lassalle Myriam, El Hallani Soufiane, Delattre Jean-Yves, Sanson Marc: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target. Cancer Cell International. 2010, 10: 1-10.1186/1475-2867-10-1.
The online version of the original article can be found at 10.1186/1475-2867-10-1
Electronic supplementary material
Additional file 1: Tumor spheroid characterization. Genomic stability was examined with CGHa analysis (left = DNA profile from the initial tumor; right = DNA profile from gliomasphere at passage p28). The chromosomes are indicated on the × axis and copy number is on y axis. Yellow indicates the normal genomic copy number, while green indicates a loss and red indicates a gain in copy number. Although some differences are observed, the comparison of both profiles shows that overall genomic profile is quite well preserved (except for an amplicon on chromosome 8 present only in the gliomasphere). (PPT 152 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Bikeye, SN.N., Colin, C., Marie, Y. et al. Erratum to: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target. Cancer Cell Int 11, 10 (2011). https://doi.org/10.1186/1475-2867-11-10